Leuprolide Acetate Injection
Product Images NDC 42023-259

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 42023-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description Image (Leuprolide Acetate Injection 1)

Chemical structure of leuprolide acetate, showing its peptide backbone and molecular composition as depicted in the image.*

FDA Label Image

Figure I (Leuprolide Acetate Injection 10)

An instructional line drawing showing a hand holding a vial of LEUPROLIDE ACETATE injection and drawing the medication into a syringe. The vial is inverted with the syringe needle inserted into the stopper, demonstrating the preparation of the subcutaneous injection.*

FDA Label Image

Figure J (Leuprolide Acetate Injection 11)

An instructional line drawing showing a hand administering a subcutaneous injection with a syringe into the forearm of another hand. The image demonstrates the proper technique for a subcutaneous injection, relevant to the administration of LEUPROLIDE ACETATE injection.*

FDA Label Image

Figure K (Leuprolide Acetate Injection 12)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe. The other hand is pressing a cloth or gauze on the injection site, which appears to be on an arm. The syringe is being pulled upward slightly after the injection.*

FDA Label Image

Figure L (Leuprolide Acetate Injection 13)

An instructional diagram showing a hand disposing of a syringe into a sharps disposal container. The container has a circular lid with a slot for syringe insertion, emphasizing safe injection waste disposal.*

FDA Label Image

Kit Carton 1 (Leuprolide Acetate Injection 14)

Packaging label for Leuprolide Acetate Injection, 14 mg/2.8 mL (1 mg/0.2 mL) by Endo USA, Inc. The label indicates the product is sterile for subcutaneous injection and includes a 14-day patient administration kit. The label shows dosage form, strength, NDC 42023-259, and storage instructions.*

FDA Label Image

Kit Carton Cont (Leuprolide Acetate Injection 15)

Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL) 14 Day Patient Administration Kit carton. The sterile subcutaneous injection is labeled for prescription use only and manufactured by Endo USA, Inc. The package includes one 2.8 mL vial of leuprolide acetate injection, 14 disposable syringes, 28 alcohol swabs, and prescribing and administration information.*

FDA Label Image

Vial Carton (Leuprolide Acetate Injection 16)

Packaging label for Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL) multi-dose vial. The sterile subcutaneous injection is labeled for Rx only and manufactured by Endo USA, Inc. The label includes dosage information, storage instructions, a barcode, and a statement to keep out of reach of children.*

FDA Label Image

Vial Label (Leuprolide Acetate Injection 17)

Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL) multi-dose vial label. The drug is for subcutaneous injection, sterile, and supplied by Endo USA, Inc. The label includes dosage instructions, storage conditions, and a barcode with lot and expiration dates.*

FDA Label Image

Figure A (Leuprolide Acetate Injection 2)

An instructional illustration depicting a hand holding a vial and drawing liquid from it using a syringe, commonly associated with preparation of a subcutaneous injection.*

FDA Label Image

Figure B (Leuprolide Acetate Injection 3)

An instructional illustration showing hands being rinsed under running water from a faucet, likely demonstrating proper handwashing technique prior to medication administration.*

FDA Label Image

Figure C (Leuprolide Acetate Injection 4)

An instructional line drawing showing a person removing a flip-off plastic cap from the top of a vial. The vial is held upright and the thumb lifts the cap detaching it from the vial's metal seal.*

FDA Label Image

Figure D (Leuprolide Acetate Injection 5)

An instructional illustration showing hands preparing a subcutaneous injection using a LEUPROLIDE ACETATE prefilled syringe. The image focuses on holding the syringe and the injection device, depicting the step before administration.*

FDA Label Image

Figure E (Leuprolide Acetate Injection 6)

An instructional illustration showing a hand holding a syringe with an arrow indicating the motion of pushing the plunger to inject the medication. The image depicts the injection technique likely related to subcutaneous administration.*

FDA Label Image

Figure F (Leuprolide Acetate Injection 7)

Black and white illustration showing two hands preparing a syringe. One hand holds the syringe near the needle, while the other hand holds a small cylindrical object being placed onto the syringe needle, suggesting preparation for injection.*

FDA Label Image

Figure G (Leuprolide Acetate Injection 8)

Illustration showing a hand holding a syringe vertically while the other hand holds a small vial or ampule at the base of the syringe. This image appears to demonstrate the process of drawing injection solution into the syringe.*

FDA Label Image

Figure H (Leuprolide Acetate Injection 9)

A black-and-white illustration showing a close-up of a hand holding a vial with a needle inserted into the vial's rubber stopper, demonstrating how to prepare or draw medication from the vial. The image is instructional for handling injection products, like subcutaneous injections.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.